Search CBIH
Cannabis Bioscience International Holdings, Inc.
OTC Markets OTCPK · CIK 1411057
Last close0
Daily change+0.00 (0.00%)
10 Years gain-99.33%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CBIH · STANDARD
SIC 8731 · Services-Commercial Physical & Biological Research · Fiscal year end 0531
Fundamental
19.9Momentum
0.0Acceleration
0.0Confidence
61.0Annual Revenue3
Quarterly Revenue17
Annual CFO3
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet6.4 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 27.4658 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 262.9491 percentage points.
Heavy share dilution · HIGHDiluted share count increased 10.7577%.
Key Metrics
Revenue Growth TTM-70.68%OK
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin60.34%OK
Operating Margin-379.49%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-1.41xOK
Diluted Share Growth 1Y10.76%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY May 31, 2025 | $303,022.00 | $262,916.00 | -$421,365.00 | -$329,627.00 | n/a | 86.76% | -139.05% | n/a | n/a | 10.72B |
| 2025 FY May 31, 2024 | $248,841.00 | $203,242.00 | -$486,140.00 | -$479,382.00 | n/a | 81.68% | -195.36% | n/a | n/a | 10.32B |
| 2024 FY May 31, 2023 | $316,825.00 | $223,375.00 | -$983,371.00 | -$898,367.00 | n/a | 70.5% | -310.38% | n/a | n/a | 9B |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $103,602.00 | sum latest 4 fiscal quarters Revenue | OK | 0001683168-26-003012, 0001683168-25-007721 |
| Revenue Growth TTM | -70.68% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001683168-26-003012, 0001683168-25-007721 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001683168-25-007174 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001683168-25-007174 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001683168-25-007174 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001683168-26-003012, 0001683168-25-007721 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 60.34% | Gross Profit / Revenue | OK | 0001683168-26-003012, 0001683168-25-007721 |
| Operating Margin | -379.49% | Operating Income / Revenue | OK | 0001683168-26-003012, 0001683168-25-007721 |
| Net Debt / CFO | -1.41x | Net Debt / CFO | OK | 0001683168-26-003012, 0001683168-26-001190 |
| Current Ratio | 0x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0x | (Cash + Short-term Investments) / Total Debt | OK | 0001683168-26-003012 |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001683168-26-003012, 0001683168-25-007721 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |